Vericel Corp (VCEL)
46.93
-0.90
(-1.88%)
USD |
NASDAQ |
May 06, 16:00
46.96
+0.03
(+0.06%)
After-Hours: 20:00
Vericel 1 Year Total Returns (Daily): 42.04% for May 6, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 06, 2024 | 42.04% |
| May 03, 2024 | 48.91% |
| May 02, 2024 | 52.82% |
| May 01, 2024 | 46.12% |
| April 30, 2024 | 45.57% |
| April 29, 2024 | 48.11% |
| April 26, 2024 | 50.69% |
| April 25, 2024 | 52.98% |
| April 24, 2024 | 52.73% |
| April 23, 2024 | 50.71% |
| April 22, 2024 | 47.34% |
| April 19, 2024 | 39.26% |
| April 18, 2024 | 42.50% |
| April 17, 2024 | 50.68% |
| April 16, 2024 | 59.30% |
| April 15, 2024 | 63.26% |
| April 12, 2024 | 58.40% |
| April 11, 2024 | 58.54% |
| April 10, 2024 | 61.25% |
| April 09, 2024 | 67.35% |
| April 08, 2024 | 66.99% |
| April 05, 2024 | 76.10% |
| April 04, 2024 | 73.80% |
| April 03, 2024 | 74.41% |
| April 02, 2024 | 74.83% |
| Date | Value |
|---|---|
| April 01, 2024 | 80.42% |
| March 28, 2024 | 84.73% |
| March 27, 2024 | 79.95% |
| March 26, 2024 | 71.07% |
| March 25, 2024 | 65.48% |
| March 22, 2024 | 65.78% |
| March 21, 2024 | 53.59% |
| March 20, 2024 | 52.81% |
| March 19, 2024 | 55.68% |
| March 18, 2024 | 50.77% |
| March 15, 2024 | 43.19% |
| March 14, 2024 | 43.40% |
| March 13, 2024 | 50.47% |
| March 12, 2024 | 51.02% |
| March 11, 2024 | 51.67% |
| March 08, 2024 | 48.29% |
| March 07, 2024 | 46.61% |
| March 06, 2024 | 50.45% |
| March 05, 2024 | 41.91% |
| March 04, 2024 | 42.90% |
| March 01, 2024 | 49.08% |
| February 29, 2024 | 50.21% |
| February 28, 2024 | 57.19% |
| February 27, 2024 | 56.40% |
| February 26, 2024 | 57.64% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-64.08%
Minimum
Jun 28 2022
650.9%
Maximum
Mar 23 2021
47.11%
Average
20.77%
Median
Sep 28 2020
1 Year Total Returns (Daily) Benchmarks
| ANI Pharmaceuticals Inc | 72.10% |
| Arbutus Biopharma Corp | 8.08% |
| Chimerix Inc | -13.36% |
| Karyopharm Therapeutics Inc | -57.56% |
| Y-mAbs Therapeutics Inc | 149.5% |